Who are TandemAI's investors?

TandemAI's investors include OrbiMed, V-Capital, KHK Fund, Qiming VP, Chengwei Ventures, Eight Roads Ventures.

Where is TandemAI headquartered?

TandemAI is headquartered in New York, New York, United States.

What industry is TandemAI in?

TandemAI operates in Artificial Intelligence, Biotech.

How many employees does TandemAI have?

TandemAI has 201-500 employees.

TandemAI

Integrate. Innovate. Discover.

New York, United States · Founded 2021

Artificial Intelligence

Biotech

Headquarters: New York, New York
Employees: 201–500
Founded: 2021
Business Model: B2B

Website: tandemai.com
Last Round: Extension RoundNov 2025
Rounds: 3

About

TandemAI is a pioneering technology company dedicated to transforming global drug discovery with advanced AI and physics-based technologies. Its platform, TandemViz, seamlessly combines proprietary AI-driven algorithms with physics-based approaches and wet lab experimentation in a cloud-based, collaborative workspace. Available as an FTE-based CRO model or standalone SaaS license, TandemAI serves 4 of the top 10 pharma companies globally and has established 100+ partnerships with a team of 350+ drug discovery experts across offices in the US and China.

Summary

TandemAI is an Artificial Intelligence company based in New York, United States, founded in 2021. Its most recent funding was an Extension Round round in Nov 2025. Investors include OrbiMed, V-Capital and KHK Fund.